Health Spotlight | Preventing relapse after CAR T-cell therapy
(WISH) — Chimeric antigen receptor T-cell therapy is revolutionizing the treatment of certain blood cancers.
CAR T-cell therapy uses genetically enhanced versions of a patient’s own cancer-fighting T-cells, offering a personalized approach that targets and destroys tumor cells.
However, one significant challenge is a high rate of relapse.
Now, a novel approach is helping to keep patients’ cancer-free for longer.
News 8s Brittany Noble has details in Monday’s Health Spotlight.
This story was created from a script aired on WISH-TV. Health Spotlight is presented by Community Health Network.
News at your fingertips! Stay informed with Indiana, Local, and National News straight to your inbox.